Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine

被引：0
|
作者：
Janne T. Backman
Marika T. Schröder
Pertti J. Neuvonen
机构：
[1] University of Helsinki and Helsinki University Central Hospital,Department of Clinical Pharmacology
[2] University of Helsinki,Department of Clinical Pharmacology
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
Gender; Smoking; Tizanidine; CYP1A2; Caffeine test;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 24
页数：7
相关论文
共 50 条
  • [1] Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine
    Backman, Janne T.
    Schroder, Marika T.
    Neuvonen, Pertti J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (01) : 17 - 24
  • [2] Effects of Mexiletine, a CYP1A2 Inhibitor, on Tizanidine Pharmacokinetics and Pharmacodynamics
    Momo, Kenji
    Homma, Masato
    Osaka, Yoshiko
    Inomata, Shin-ichi
    Tanaka, Makoto
    Kohda, Yukinao
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (03): : 331 - 337
  • [3] Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - Probes of CYP2C9, CYP1A2, and CYP3A4
    Lilja, J. J.
    Backman, J. T.
    Neuvonen, P. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (06) : 833 - 839
  • [4] Evaluation of tizanidine as a marker of canine CYP1A2 activity
    Locuson, C. W.
    Williams, P.
    Adcock, J. M.
    Daniels, J. S.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (02) : 122 - 130
  • [5] Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAFV600 Mutation-Positive Malignancies
    Zhang, Weijiang
    McIntyre, Christine
    Riehl, Todd
    Forbes, Harper
    Bertran, Enric
    Choi, Hye Jin
    Lee, Dae Ho
    Lee, Jeeyun
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (05): : 651 - 658
  • [6] Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity
    Härtter, S
    Nordmark, A
    Rose, DM
    Bertilsson, L
    Tybring, G
    Laine, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) : 679 - 682
  • [7] CYP1A2' HYPERINDUCER' GENOTYPE DOES NOT CORRELATE WITH CYP1A2 PHENOTYPE IN NON-SMOKING, MODERATE COFFEE DRINKERS.
    Tian, D.
    Natesan, S.
    White, J. R.
    Paine, M. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S53 - S53
  • [8] CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine
    Carrillo, JA
    Benitez, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (06) : 605 - 608
  • [9] Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice
    Muhamad, Nadda
    Plengsuriyakarn, Tullayakorn
    Na-Bangchang, Kesara
    PLOS ONE, 2022, 17 (11):
  • [10] Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2
    Buters, JTM
    Tang, BK
    Pineau, T
    Gelboin, HV
    Kimura, S
    Gonzalez, FJ
    PHARMACOGENETICS, 1996, 6 (04): : 291 - 296
12345